ArticleJTCVS open2026
Increasing adoption of donation after circulatory death in high-risk heart transplant recipients: Insights into current practices in the United States.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Previous reports indicate that the majority of donation after circulatory death (DCD) heart transplants (HTs) were performed in low-priority candidates (status ≥4). We sought to characterize the contemporary practice and outcomes of DCD HTs in high- and low-risk patients. Methods: Using the United Network for Organ Sharing database, 1581 adult HT recipients (2019-2024) were identified: 966 (61%) high risk (status 1-3) and 615 (39%) low risk (status 4-6). Trends in recipient selection, waitlist time, and posttransplant outcomes were examined. Results: High-risk patients were more likely to be younger (56 vs 59 years; Conclusions: Over the past 5 years, the practice of DCD HT has evolved, with most transplants now occurring in high-risk candidates, yielding comparable outcomes to lower-risk groups. However, DCD waitlist times have significantly increased, suggesting the need for broader and earlier adoption across all listing statuses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.